On 6 May 2025, the Securities and Futures Commission (SFC) and The Stock Exchange of Hong Kong Limited (Exchange) issued a Joint Announcement on Launch of Technology Enterprises Channel (TECH), a new initiative designed to streamline the listing process for Specialist Technology Companies (under Chapter 18C of the Listing Rules) and Biotech Companies (under Chapter 18A of the Listing Rules). The initiative also introduces a confidential filing option for these companies, addressing concerns around premature disclosure of sensitive business and technological information. This initiative continues to underscore Hong Kong’s commitment to supporting the listing of quality companies, further enhancing the city's appeal as an international financial centre.
Key Features of TECH
The TECH initiative builds on Hong Kong’s recent reforms, including the introduction of Chapter 18A (Biotech Companies) and Chapter 18C (Specialist Technology Companies) listing regimes, to ensure Hong Kong remains competitive in attracting high-growth listings.
1. Early and Tailored Regulatory Guidance
TECH provides prospective issuers with pre-submission support to help them navigate Hong Kong’s listing regime more efficiently. Key measures include:
- A dedicated team with expertise in reviewing Chapter 18A (Biotech Companies) and Chapter 18C (Specialist Technology Companies) applications.
- Early engagement to discuss business models, eligibility, and compliance with Listing Rules.
- Preliminary guidance on sector-specific requirements, including:
- Core Product qualifications for Biotech Companies;
- Recognition of clinical trials conducted under different regulatory regimes for Biotech Companies;
- Assessment of Sophisticated Investors; and
- Acceptable sectors for Specialist Technology Industries.
2. Confidential Filing Option
Given the sensitive nature of proprietary technologies and early-stage business strategies, TECH allows Specialist Technology Companies and Biotech Companies to submit Application Proofs confidentially. This mitigates risks associated with prolonged exposure of competitive information.
3. Presumed Eligibility for Weighted Voting Rights (WVR) Structures
The Exchange has updated its Guide for New Listing Applicants to clarify that Specialist Technology Companies and Biotech Companies meeting Chapters 18C and 18A respectively will be presumed to satisfy the following for listing with a WVR structure and will qualify as innovative companies for the purposes of Chapter 8A:
- The Innovative Company Requirements; and
- The external validation requirement (typically fulfilled through pre-IPO investments by Sophisticated Investors).
These presumptions simplify the path for innovative companies seeking to adopt dual-class (or weighted voting) share structures, aligning with global practices for high-growth tech firms.
Companies exploring a Hong Kong listing under Chapters 18A or 18C can now engage the Exchange via their dedicated TECH webpage.
Conclusion
The TECH initiative underscores Hong Kong’s commitment to reinforcing its position as a leading premier listing hub for high-growth, innovative companies. Key takeaways include:
- Enhanced efficiency: Early engagement reduces regulatory uncertainty and accelerates IPO timelines.
- Investor protection: While facilitating listings, the SFC and the Exchange maintain robust safeguards, ensuring market integrity.
- Strengthened competitiveness: The confidential filing option brings Hong Kong closer to practices in other markets, making it more attractive for early-stage tech and biotech firms.
For further details or support, please do not hesitate to contact us.
